Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
申请人:MERCK & CO. INC.
公开号:EP1036563A1
公开(公告)日:2000-09-20
The instant invention provides orally administrable pharmaceutical compositions suitable for inhibiting HMG-CoA reductase, as well as for treating and/or reducing the risk for diseases and conditions affected by inhibition of HMG-CoA reductase, comprising a therapeutically effective amount of a statin selected from dihydroxy open acid simvastatin and a pharmaceutically acceptable salt or ester thereof in a delayed-release dosage form wherein substantial release of the compound from the dosage form is delayed until after passage of the dosage form through the stomach.